New research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning ...

At 24 months, endocrine therapy appeared to have a more negative effect on HRQOL as measured by the global health status (GHS ...

Women with a type of low-risk cancer might not have to rush aggressive treatment, doctors say.

It’s been long known that women with BRCA1 and BRCA2 gene mutations are at higher risk for breast and ovarian cancer. More ...

Black women experience advanced diagnoses 55% more often than white women and are more likely to die from the disease, the ...

Outside experts say, however, that the choice of control group in the trial may limit the relevance to clinical practice.

A "watch-and-wait" strategy might be the best option for some women with early-stage, low-risk breast cancer.

Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk ...

Research presented at the San Antonio Breast Cancer Symposium suggests women with early-stage breast cancer could safely ...

A new study, published in the New England Journal of Medicine, examines whether removing lymph nodes is always necessary in ...

A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer, a study suggests.

A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either ...